Impact of tumour associated macrophages in pancreatic cancer

Ainhoa Mielgo1, Michael C Schmid

  • 1Liverpool Cancer Research UK Centre, Liverpool L7 8XP, UK.

BMB Reports
|March 27, 2013
PubMed

Insights

Tumor-associated macrophages (TAMs) promote pancreatic cancer progression by fostering angiogenesis and immune suppression. Targeting TAMs offers a promising therapeutic strategy to improve pancreatic cancer treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Myeloid cells, including macrophages, accumulate in tumors, creating a pro-tumor microenvironment.
  • Pancreatic ductal adenocarcinoma (PDA) is characterized by significant macrophage infiltration and desmoplastic stromal reactions, impacting disease progression and therapy response.

Purpose of the Study:

  • To review the biology and pro-tumorigenic functions of tumor-associated macrophages (TAMs) in cancer, with a specific focus on pancreatic ductal adenocarcinoma (PDA).
  • To highlight potential therapeutic strategies targeting TAMs to enhance current pancreatic cancer therapies.

Main Methods:

  • Literature review of current understanding of TAM biology and function in cancer.
  • Focus on TAM roles in PDA, including angiogenesis, metastasis, immune suppression, chemotherapy resistance, and cancer stem cell emergence.

Main Results:

  • TAMs significantly contribute to PDA progression by promoting angiogenesis, metastasis, and immune evasion.
  • TAMs are implicated in resistance to chemotherapy and the development of cancer stem-like cells in PDA.

Conclusions:

  • Understanding TAM biology is crucial for developing effective pancreatic cancer treatments.
  • Targeting TAMs represents a promising therapeutic avenue to overcome treatment resistance and improve patient outcomes in pancreatic cancer.